1191244-95-7

Upstream product

• 1191245-10-9 ethyl 3-(3,5-dichloro-4-hydroxyphenyl)-1H-1,2,4-triazole-5-carboxylate 
• 1191245-11-0 butyl 3-(3,5-dichloro-4-hydroxyphenyl)-1H-1,2,4-triazole-5-carboxylate 
• 5635-67-6 (3,4-dichlorobenzyl)(methyl)amine 
• 1191397-31-5 (Z)-ethyl 2-amino-2-(2-(3,5-dichloro-4-hydroxybenzoyl)hydrazono)acetate 
• 71-36-3 butan-1-ol 

Relevant academic research and scientific papers

Compounds, Compositions and Methods Comprising Triazole Derivatives

The present invention relates to compositions and methods for treating a disease in an animal, which disease is responsive to inhibiting of functional cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide by administering to a mammal in need thereof an effective amount of a compound defined herein (including those compounds set forth in Tables 1-2 or encompassed by formulas I-II) or compositions thereof, thereby treating the disease. The present invention particularly, relates to a method of treating diarrhea and polycystic kidney disease.

Compounds, Compositions and Methods Comprising Heteroaromatic Derivatives

The present invention relates to compositions and methods for treating a disease in an animal, which disease is responsive to inhibiting of functional cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide by administering to a mammal in need thereof an effective amount of a compound defined herein (including those compounds set forth in Tables 1-14 or encompassed by formulas I-XII) or compositions thereof, thereby treating the disease. The present invention particularly, relates to a method of treating diarrhea and polycystic kidney disease.